Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Vaccination is crucial for public health, but anti-vaccine movements are a concern.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Ringworm in pets is influenced by fungi type, immune status, and stress hormones.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

The health of the gut may be important in developing new ways to prevent, diagnose, and treat alopecia areata.

Corneodesmosin is essential for skin and hair health, and its dysfunction can lead to skin and hair disorders.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Baricitinib effectively regrows hair in severe alopecia areata cases.

BMS-470539 reduces skin fibrosis and inflammation.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Erianin may effectively treat alopecia areata by targeting the immune system.

Tofacitinib helped regrow hair in most patients with severe hair loss.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

RDW can be a useful marker for inflammation in alopecia areata patients.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.